ASCO/ASTRO/AUA/SUFU Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer Guideline Summary - Guideline Central

Document Overview

Document Title
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer
Authoring Societies

American Society for Radiation Oncology

American Society of Clinical Oncology

American Urological Association

Society of Urodynamics Female Pelvic Medicine & Urogenital Reconstruction

Document Publication Date
Apr 26, 2017
Page Last Reviewed/Updated
May 6, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.ncbi.nlm.nih.gov/pmc/articles/PMC5626446/
Source Citation

Chang, S. S., Bochner, B. H., Chou, R., Dreicer, R., Kamat, A. M., Lerner, S. P., Lotan, Y., Meeks, J. J., Michalski, J. M., Morgan, T. M., Quale, D. Z., Rosenberg, J. E., Zietman, A. L., & Holzbeierlein, J. M. (2017). Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. The Journal of urology198(3), 552–559. https://doi.org/10.1016/j.juro.2017.04.086


Supplemental Implementation Resources


Document Scope, Criteria, and Use Cases

Document Objectives
This multi-disciplinary, evidence-based guideline for clinically non-metastatic muscle-invasive bladder cancer focuses on the evaluation, treatment, and surveillance of muscle-invasive bladder cancer guided toward curative intent.
Scope
Assessment and Screening, Management, Treatment
Diseases/Conditions (MeSH)

D011878 - Radiotherapy

D001749 - Urinary Bladder Neoplasms

D000072281 - Lymphadenopathy

D015653 - Cystectomy

D011878 - Radiotherapy

D001749 - Urinary Bladder Neoplasms

D000072281 - Lymphadenopathy

D015653 - Cystectomy

Keywords
Bladder Preservation, Non-Metastatic cancer, bladder cancer
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older Adult
Health Care Settings
Hospital, Operating and Recovery Room, Outpatient, Radiology Services
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant, Radiology Technologist

Recommendation Development Processes & Methodology

Number of Source Documents
331
Literature Search Start Date
Monday, January 1, 1990
Literature Search End Date
Monday, May 18, 2020
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
No
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.